Niloufar Marsousi

605 total citations
17 papers, 272 citations indexed

About

Niloufar Marsousi is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Niloufar Marsousi has authored 17 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Niloufar Marsousi's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Niloufar Marsousi is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Niloufar Marsousi collaborates with scholars based in Switzerland, United States and Italy. Niloufar Marsousi's co-authors include Youssef Daali, Serge Rudaz, Jules Desmeules, Caroline Samer, Pierre Fontana, Jean‐Luc Reny, Alexandra Calmy, Dany Spaggiari, Lisa M. Almond and Philippe J. Eugster and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Pharmaceutical Sciences.

In The Last Decade

Niloufar Marsousi

16 papers receiving 269 citations

Peers

Niloufar Marsousi

PHARM

CCM

PHARM

PPCH

Jin Ah Jung South Korea

PE Rolan United Kingdom

Michael E. Franklin Australia

Kosuke Doki Japan

Shuaibing Liu China

Seong Bok Jang South Korea

Phyllis Yerino United States

Hannah Britz Germany

Jan L. Maxa United States

Anil Pareek India

Jin Ah Jung South Korea

Niloufar Marsousi

77 ×0.9

PHARM

58 ×1.2

CCM

72 ×1.6

PHARM

75 ×1.7

65 ×1.6

PPCH

Citations per year, relative to Niloufar Marsousi Niloufar Marsousi (= 1×) peers Jin Ah Jung

Countries citing papers authored by Niloufar Marsousi

Since Specialization

Citations

This map shows the geographic impact of Niloufar Marsousi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niloufar Marsousi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niloufar Marsousi more than expected).

Fields of papers citing papers by Niloufar Marsousi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niloufar Marsousi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niloufar Marsousi. The network helps show where Niloufar Marsousi may publish in the future.

Co-authorship network of co-authors of Niloufar Marsousi

This figure shows the co-authorship network connecting the top 25 collaborators of Niloufar Marsousi. A scholar is included among the top collaborators of Niloufar Marsousi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niloufar Marsousi. Niloufar Marsousi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Gerds, Aaron T., Claire Harrison, Jean‐Jacques Kiladjian, et al.. (2024). Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis. Blood Advances. 8(17). 4511–4522. 15 indexed citations

Gerds, Aaron T., Claire Harrison, Jean‐Jacques Kiladjian, et al.. (2023). Clinical Parameters, Anemia, and Spleen Response in Patients with MF-Related Anemia Treated with Luspatercept: Efficacy Sub-Analysis from the ACE-536-MF-001 Study. Blood. 142(Supplement 1). 4565–4565. 1 indexed citations

Jeyaraju, Danny V., Sheida Hayati, Niloufar Marsousi, et al.. (2023). Predictive Biomarkers of Response to Luspatercept in Patients with Myelofibrosis- (MF) Associated Anemia: Biomarker Analysis from the ACE-536-MF-001 Study. Blood. 142(Supplement 1). 6330–6330. 1 indexed citations

Komrokji, Rami S., Aaron T. Gerds, Claire Harrison, et al.. (2023). Longitudinal Safety of Luspatercept in the Treatment of Anemia in Patients with Myelofibrosis: Results from the ACE-536-MF-001 Study. Blood. 142(Supplement 1). 1820–1820. 1 indexed citations

Gerds, Aaron T., Claire Harrison, Jean‐Jacques Kiladjian, et al.. (2023). S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY. HemaSphere. 7(S3). e0882611–e0882611. 2 indexed citations

Gerds, Aaron T., Claire Harrison, Jean‐Jacques Kiladjian, et al.. (2023). Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis: Results from the ACE-536-MF-001 study.. Journal of Clinical Oncology. 41(16_suppl). 7016–7016. 4 indexed citations

Marsousi, Niloufar, Serge Rudaz, Jules Desmeules, & Youssef Daali. (2019). Liquid Chromatography-Tandem Mass Spectrometry Method for Ticagrelor and its Active Metabolite Determination in Human Plasma: Application to a Pharmacokinetic Study. Current Analytical Chemistry. 16(5). 602–608. 3 indexed citations

Marsousi, Niloufar, Youssef Daali, Pierre Fontana, et al.. (2018). Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites. Clinical Pharmacokinetics. 57(10). 1347–1354. 52 indexed citations

Marsousi, Niloufar, Jules Desmeules, Serge Rudaz, & Youssef Daali. (2017). Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine. Journal of Pharmaceutical Sciences. 106(9). 2380–2391. 57 indexed citations

10.

Marsousi, Niloufar, Jules Desmeules, Serge Rudaz, & Youssef Daali. (2017). Prediction of drug‐drug interactions using physiologically‐based pharmacokinetic models of CYP450 modulators included in Simcyp software. Biopharmaceutics & Drug Disposition. 39(1). 3–17. 33 indexed citations

11.

Spaggiari, Dany, Niloufar Marsousi, Caroline Samer, et al.. (2016). Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases. Journal of Pharmaceutical and Biomedical Analysis. 144. 129–137. 22 indexed citations

12.

Marsousi, Niloufar, et al.. (2016). Intestinal permeability and P‐glycoprotein‐mediated efflux transport of ticagrelor in Caco‐2 monolayer cells. Fundamental and Clinical Pharmacology. 30(6). 577–584. 22 indexed citations

13.

Marsousi, Niloufar, Caroline Samer, Pierre Fontana, et al.. (2016). Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach. Clinical Pharmacology & Therapeutics. 100(3). 295–304. 33 indexed citations

14.

Marsousi, Niloufar, et al.. (2014). Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model. CPT Pharmacometrics & Systems Pharmacology. 3(12). 1–8. 16 indexed citations

15.

Marsousi, Niloufar, et al.. (2013). Influence of genetic polymorphisms on the response variability to opioids.

16.

Marsousi, Niloufar, et al.. (2013). Influence des polymorphismes génétiques sur la variabilité de la réponse aux opioïdes. Douleur et Analgésie. 26(4). 203–208. 2 indexed citations

17.

Ho, Raimana, Niloufar Marsousi, Philippe J. Eugster, Jean‐Pierre Bianchini, & Phila Raharivelomanana. (2009). Detection by UPLC/ESI-TOF-MS of Alkaloids in Three Lycopodiaceae Species from French Polynesia and Their Anticholinesterase Activity. Natural Product Communications. 4(10). 1349–52. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact